1. Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Lacrampe, J., Janssens, F., 2000. R170591, a novel fusion inhibitor with picomolar activity against respiratory syncytial virus (RSV). Abstract 11640th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17–20 September 2000.
2. Anonymous, 1996. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 97 (1), 137–140.
3. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin;Bitko;Virology,1997
4. Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane;Dubovi;Virology,1980
5. Local and systemic cytokine responses during experimental human influenza A virus infection;Hayden;J. Clin. Invest.,1998